Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Jan 31, 2023 10:20am
234 Views
Post# 35256557

RE:The Head, The Heart and The Gut

RE:The Head, The Heart and The Gut
N0taP00p wrote: My head says: This is a Canadian penny stock that's been languishing in the trenches for a dozen plus years.  No one knows about this company. There is a lack of management trust. An inability to raise money with decent terms and with the backing of its science and clinical data.  They will delay again and make excuses. The longs will explain it away. Groundhog Day every day. 

My Heart says: Breakthrough drugs require a lot of toil, trial and errors. If this were in the US, might have been a different story in terms of financing, publicity , opportunities for collaboration, etc. It's going to break to the upside very soon. Bladders Forever, with Rutherrin instead of Vibranium. Waiting to be discovered by the world. 

My Gut?  My gut says, if they miss this Q1 deadline for whatever reason, I must  say Goodbye Forever to 50 percent of my shares and defer to the head, going forward. 



Poop, I hear ya. This stock is constantly overlooked cuz it's in Canada, on the Venture X. Yet I think they are just waiting on Clinicians to compile data. I don't think they are waiting until RW is back at the helm, yet that happens middle of next month. I don't think they will miss the Q1 deadline....
<< Previous
Bullboard Posts
Next >>